The 2017 Russian Pharmaceutical Exhibition PharmTech was a perfect showcase.
Detailed introduction
The Russian International Exhibition for Pharmaceuticals and Pharmaceutical Ingredients, Pharmingredients & PharmTech, is a highly specialized and large-scale event dedicated to the pharmaceutical industry in Russia and the CIS countries. Among them, Pharmtech focuses on pharmaceutical equipment, showcasing a comprehensive range of cutting-edge technologies and equipment covering pharmaceutical materials, quality control, laboratory equipment, packaging technologies, transportation technologies, and storage solutions. Meanwhile, the Russian government hopes that foreign companies will help Russia achieve pharmaceutical innovation and, through platforms provided by multinational corporations, transform Russia into a major active pharmaceutical ingredient (API) production base. Many multinational corporations that have established factories in Russia still rely on centralized production for their APIs; only 15% of APIs consumed in the Russian pharmaceutical market are produced domestically, and among Russia’s more than 400 biopharmaceutical and pharmaceutical factories, fewer than 10% meet high-quality standards.
In recent years, Chinese pharmaceutical companies have stepped up their pace of entry into overseas markets, and Sino-Russian pharmaceutical trade has been developing rapidly. As one of the most promising emerging overseas markets, from November 21 to November 24, 2017, Shanghai Luxiangyi Centrifuge Instrument Co., Ltd. brought along its high-quality centrifuge products developed in recent years, as well as technical staff, to participate in a four-day exhibition at the Russian Pharmaceutical Expo.
During the exhibition, numerous biotech and pharmaceutical companies visited our company’s booth for consultations. We learned that the on-site exhibitors were particularly interested in the pharmaceutical centrifuges manufactured by Luxiangyi, which offer effective solutions to the challenges they face in purifying active pharmaceutical ingredients during the manufacturing process. They expressed their willingness to strengthen cooperation in future communications and provide high-quality centrifugal equipment to support their pharmaceutical production.